The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens

Authors:	Mehmet Artac Hakan Bozcuk Sacide Pehlivan Songül Akcan Mustafa Pehlivan Tugce Sever Mustafa Ozdogan Burhan Savas

Affiliation:	(1) Department of Medical Oncology, Meram Medical Faculty, Selcuk University, Meram, 42080 Konya, Turkey;(2) Department of Medical Oncology, Medical Faculty, Akdeniz University, Antalya, Turkey;(3) Department of Medical Biology, Medical Faculty, Gaziantep University, Gaziantep, Turkey;(4) Department of Internal Medicine, Medical Faculty, Akdeniz University, Antalya, Turkey;(5) Department of Hematology, Medical Faculty, Gaziantep University, Gaziantep, Turkey

Abstract:	Background Previous studies have suggested that DNA repair enzyme polymorphisms may bear prognostic value in metastatic colorectal carcinoma (MCRC).

Keywords:
本文献已被 SpringerLink 等数据库收录！